Press Releases

For information, Après-demain SA and Debiopharm Investment SA merged in March 2020.
2 September 2013

KeyLemon secures Series A Investment co-led by Debiopharm Investment and Swisscom ventures

Read more
17 January 2013

Debiopharm Group participates in first round of financing for compliant concept, an Empa and ETH Zurich spin-off bound for success…

Read more